Impact of Personalised Cardiac Anaesthesia and Cerebral Autoregulation on Neurological Outcomes in Patients Undergoing Cardiac Surgery
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Oct 24, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how personalized cardiac anesthesia and monitoring of blood flow to the brain can affect the risk of neurological problems after heart surgery. Researchers want to find out if patients whose blood pressure goes outside of a safe range during surgery are more likely to experience issues like confusion, stroke, or memory problems afterward. They will also look at how certain biological markers and genetic factors might relate to these neurological outcomes.
To participate in this study, you need to be scheduled for elective heart surgery, such as a bypass or valve surgery, that requires a heart-lung machine. Unfortunately, if you are having emergency surgery, a transplant, or certain types of surgeries that involve deep cooling of the body, you won’t be eligible. If you join the study, you'll have your blood pressure and brain blood flow monitored during your surgery, and researchers will follow up with you afterward to check on your recovery. This study is currently recruiting participants, so if you meet the criteria, there may be an opportunity for you to contribute to important research in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Elective primary or reoperative coronary artery bypass graft and/or valvular and/or ascending aorta surgery requiring cardiopulmonary bypass.
- Exclusion Criteria:
- • Surgery requiring moderate or deep hypothermic circulatory arrest;
- • Heart and/or lung transplantation;
- • Urgent (\< 24 hours) and emergency surgery;
- • Inability to follow procedures or insufficient knowledge in English, German or French;
- • Inability to give consent.
- • Participants from the University Hospital Basel who undergo cardiac surgery under minimal extracorporeal circulation will also be excluded.
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Dresden, , Germany
Basel, , Switzerland
Cambridge, , United Kingdom
Dresden, , Germany
Cambridge, , United Kingdom
Cambridge, , United Kingdom
Patients applied
Trial Officials
Nuno V. Gomes, MD
Principal Investigator
Clinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials